Pharma Reviews: Fosun Group injects new life into Gland Pharma deal
Fosun Pharma said it would spend no more than $25 million for the Indian firm's Enoxaparin prototype sales in the US, when it gets approval there, ...
Read more: Fosun Group injects new life into Gland Pharma deal